Google (GOOGL) launches OpenAI models through its cloud
Newsquawk Staff ·
- OpenAI's GPT-Astra, GPT-6.1 Sol and GPT-6 Luna models rolling out in private preview to select enterprise customers via Google Cloud's Model Garden.
What it means
Distribution of OpenAI models on a rival cloud marks another step in the erosion of the exclusive Azure relationship that once defined the OpenAI-Microsoft structure, a loosening that has unfolded gradually through prior compute and hosting arrangements outside Azure. The pattern in cloud AI has been convergence toward marketplace models: providers have tended to host competing frontier models in curated gardens rather than rely on a single exclusive anchor, since enterprise buyers demand choice and the hosts monetise inference capacity regardless of model origin. For Microsoft the relevant question is not whether Azure loses OpenAI workloads outright, which it has not, but where the marginal enterprise commitment lands once model access is no longer a differentiator, shifting competition to price, tooling and capacity. For Google the arrangement fits its established posture of positioning its cloud as the neutral multi-model venue, a pitch aimed at share gains against the larger incumbent. What separates the cases is private preview status: early access for select enterprise customers is a demand signal and a negotiating artifact rather than a revenue event, and past previews of this kind have run for an extended period before general availability. The tells worth tracking are timing of general availability, whether Azure exclusivity terms are formally revised, and any commentary from either side on how inference revenue is shared across platforms.
Sources
- CrowdStrike (CRWD) and Nvidia (NVDA) expand AI agent security to silicon; By 2028, production for Nvidia to account for significant portion of annual substrate capacity
- Oracle (ORCL) launches an AI agent studio for industry applications
- Newsquawk Daily European Opening News - 21st October 2026
- PRE-MARKET TAIWANESE AND SINGAPOREAN STOCK NEWS: Zhen Ding sees no near-term relief in PCB supply constraints; Singapore banks take zero-tolerance stance on haze-linked clients
- PRE-MARKET JAPANESE AND SOUTH KOREAN STOCK NEWS: Nidec probe holds five former presidents liable; Tsugami lifts H1 profit view; LIG D&A hit with two-year bidding ban
Related headlines
- [EARNINGS CALL] Netflix (NFLX) says there's no need for a fundamental shift in the strategy, but do need better execution in the US15 hours ago
- NVIDIA (NVDA) and Supply Chain Partners expand capacity to accelerate AI infrastructure buildout1 hour ago
- European Commission opened an investigation into Booking.com (BKNG) amidst concerns related to scams and fraud listings2 hours ago
- Nvidia (NVDA) CEO says the Co. has invested almost USD 10bln across Europe over the past year and announced investments in 14 European startups in the past week3 hours ago
- Micron (MU) reaches a labour-management agreement with Taichung union, with both parties agreeing to withdraw from the mediation process scheduled for October 22nd6 hours ago
- US President Trump says the Pentagon will invest USD 1.5bln in semiconductor chip production in North Carolina11 hours ago
- [EARNINGS CALL] SpaceX (SPCX) CEO Musk says a merger between SpaceX and Tesla (TSLA) would be a good idea but is far from certain, noting that shareholder support is required, including approval from 50% of all Tesla shares15 hours ago
- US Market Wrap: Tech lags in wider-stock rally 16 hours ago
- EUROPEAN OPEN: SPCX up after results, TSLA merger talks; SMCI surges on raised outlook; ADS GY beat and raise; DB1 GY beat and raise; CA FP cuts outlook on weak French demand; Belgium pressure to sell BNP FP stake; EQT SS advances on QIA GY 5 hours ago
- eBay (EBAY) reportedly cutting 9% of workforce to simplify operations and prioritise growth areas39 min ago
- Abbott Laboratories (ABT) Q3 2026 (USD): Adj. EPS 1.42 (exp. 1.42), Revenue 13.0bln (exp. 12.99bln)59 min ago
- Abbott (ABT) announced its intention to separate its Nutrition business into an independent, publicly traded company with approximately USD 8.5bln in annual sales and a portfolio of brands1 hour ago
- CME Group Inc. (CME) Q3 2026 (USD): Adj. EPS 3.02 (exp. 2.98), Revenue 1.7bln (exp. 1.71bln)1 hour ago
- Moody's (MCO) Q3 2026 (USD): Adj. EPS 4.14 (exp. 4.24), Revenue 2.023bln (exp. 2.07bln)1 hour ago
- European Commision has improved Merck's (MRK) Keytruda plus Padcev, as perioperative treatment1 hour ago